FORT LAUDERDALE, Fla., April 11 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc. (BULLETIN BOARD: IMDS) announced that the company would fulfill a request by Professor B. Maciejewski, MD, PhD, FACR, Director of the Institute of Oncology, Center of Oncology, of the Maria Sklodowska- Curie Memorial Institute in Poland ( http://www.io.gliwice.pl/ ) to install a second CT Laser Mammography system for clinical research.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
Professor Maciejewski noted that the additional CTLM was needed to "intensify the whole project." The first system was installed in January 2005 and patient volumes have continued to increase.
"We are very pleased with the rapid acceptance of the CT laser breast imaging procedure among the women patients. Professor Maciejewski's team has made an excellent effort to introduce CTLM to the region and to develop several research protocols that are of great interest to the Oncology Center and IDSI," commented Deborah O'Brien, IDSI Senior Vice President.
The CTLM(R) system is the first patented breast imaging system that utilizes state-of the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com/ for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.CONTACT: Rick Lutz, +1-404-261-1196, or lcgroup@mindspring.com, forImaging Diagnostic Systems, Inc.